IIIB NSCLC

Related by string. * IIIb : ongoing Phase IIIb . Phase IIIb clinical . Phase IIIb study . Stage IIIB IV . confirmatory Phase IIIb . CAT IIIB . IIIB . Phase IIIB IV . stage IIIB IV . stage IIIb IV . Interim Stage IIIB / : IIIA NSCLC . non squamous NSCLC . metastatic NSCLC . IV NSCLC . NSCLC tumors . recurrent NSCLC . refractory NSCLC . advanced NSCLC . advanced nonsquamous NSCLC . lung cancer NSCLC * *

Related by context. Frequent words. (Click for all words.) 61 evaluable 60 evaluable patients 58 vandetanib 58 advanced NSCLC 57 follicular lymphoma 57 NSCLC 57 FOLFOX 57 tumor shrinkage 56 free survival PFS 56 CTCL 55 systemic lupus erythematosus SLE 55 sunitinib 55 renal cell carcinoma 55 metastatic prostate cancer 55 liver metastases 55 relapsing remitting multiple sclerosis 54 metastatic disease 54 cetuximab 54 myelofibrosis 54 tumor recurrence 54 peginterferon 54 adalimumab 53 chronic lymphocytic leukemia CLL 53 metastatic melanoma 53 chronic myeloid leukemia CML 53 relapsing remitting MS 53 cutaneous T cell 53 systemic lupus erythematosus 53 diabetic nephropathy 53 HER2 positive breast cancer 53 rituximab 53 gefitinib 53 dasatinib 53 IMGN# 52 hepatocellular carcinoma 52 mg BID 52 fludarabine 52 adjuvant chemotherapy 52 metastatic 52 squamous cell carcinoma 52 Torisel 51 microalbuminuria 51 metastatic colorectal cancer 51 metastatic breast cancer 51 temozolomide 51 metastatic cancer 51 solid tumors 51 postherpetic neuralgia 51 HER2 positive 51 fluorouracil 51 sorafenib 51 hormone refractory prostate cancer 51 DMARDs 51 Median survival 51 hematologic 51 rheumatoid arthritis RA 51 renal insufficiency 51 carcinoma 51 GIST 51 INCB# [002] 51 ulcerative colitis 51 adjuvant therapy 51 brain metastases 51 acute myeloid leukemia 50 squamous cell 50 RG# [001] 50 pegylated interferon 50 erlotinib 50 macular edema 50 pemetrexed 50 Rituximab 50 tumor regression 50 carboplatin 50 cell lung cancer 50 imatinib 50 uveitis 50 severe plaque psoriasis 50 bronchiectasis 50 bone metastases 50 plus ribavirin 49 carcinomas 49 cell carcinoma 49 localized prostate cancer 49 basal cell carcinoma 49 mitoxantrone 49 febrile neutropenia 49 RRMS 49 retinopathy 49 HRPC 49 unstable angina 49 infliximab 49 abatacept 49 methotrexate 49 gemcitabine 49 glioblastoma 49 chronically infected 48 tiotropium 48 bortezomib 48 oral mucositis 48 FOLOTYN 48 renal dysfunction

Back to home page